Grimes & Company, Inc. Boston Scientific Corp Transaction History

Grimes & Company, Inc.

$3.22 Billion
Q1 2024

A detailed history of Grimes & Company, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Grimes & Company, Inc. holds 8,123 shares of BSX stock, worth $618,241. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,123

Previous 7,979 1.8%

Holding current value

$618,241

Previous $461,000 20.61%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$57.6 - $68.62 $8,294 - $9,881	144 Added 1.8%	8,123 $556,000
Q4 2023 Jan 24, 2024	SELL	$48.64 - $57.81 $5,934 - $7,052	-122 Reduced 1.51%	7,979 $461,000
Q3 2023 Oct 19, 2023	SELL	$50.19 - $54.68 $50 - $54	-1 Reduced 0.01%	8,101 $427,000
Q2 2023 Jul 19, 2023	SELL	$49.72 - $54.64 $99 - $109	-2 Reduced 0.02%	8,102 $438,000
Q1 2023 Apr 20, 2023	BUY	$45.09 - $50.03 $4,644 - $5,153	103 Added 1.29%	8,104 $405,000

Q4 2022 Jan 25, 2023	BUY	$39.56 - $47.22 $2,175 - $2,597	55 Added 0.69%	8,001 $0
Q3 2022 Oct 28, 2022	BUY	$36.71 - $109.66 $146 - $438	4 Added 0.05%	7,946 $308,000
Q1 2022 May 06, 2022	SELL	$40.9 - $45.1 $6,380 - $7,035	-156 Reduced 1.93%	7,942 $352,000
Q4 2021 Feb 01, 2022	SELL	$38.07 - $44.87 $89,540 - $105,534	-2,352 Reduced 22.51%	8,098 $344,000
Q3 2021 Nov 08, 2021	BUY	$41.23 - $45.88 $3,504 - $3,899	85 Added 0.82%	10,450 $453,000
Q2 2021 Aug 04, 2021	SELL	$38.58 - $44.24 $19,097 - $21,898	-495 Reduced 4.56%	10,365 $443,000
Q1 2021 May 12, 2021	SELL	$35.27 - $39.67 $17,458 - $19,636	-495 Reduced 4.36%	10,860 $420,000
Q4 2020 Feb 02, 2021	SELL	$33.15 - $41.97 $16,409 - $20,775	-495 Reduced 4.18%	11,355 $408,000
Q3 2020 Nov 12, 2020	SELL	$34.44 - $42.23 $15,807 - $19,383	-459 Reduced 3.73%	11,850 $453,000
Q2 2020 Jul 31, 2020	SELL	$30.19 - $39.11 $273,310 - $354,062	-9,053 Reduced 42.38%	12,309 $432,000
Q1 2020 May 05, 2020	BUY	$25.83 - $45.71 $24,874 - $44,018	963 Added 4.72%	21,362 $697,000
Q4 2019 Feb 05, 2020	BUY	$37.87 - $45.37 $414,487 - $496,574	10,945 Added 115.77%	20,399 $922,000
Q3 2019 Nov 05, 2019	SELL	$40.31 - $43.45 $37,689 - $40,625	-935 Reduced 9.0%	9,454 $384,000
Q2 2019 Jul 30, 2019	SELL	$34.91 - $42.98 $20,771 - $25,573	-595 Reduced 5.42%	10,389 $447,000
Q1 2019 May 02, 2019	BUY	$32.91 - $40.75 $16,619 - $20,578	505 Added 4.82%	10,984 $422,000
Q4 2018 Feb 01, 2019	BUY	$31.73 - $39.04 $13,516 - $16,631	426 Added 4.24%	10,479 $370,000
Q2 2018 Aug 10, 2018	SELL	$26.84 - $34.32 $8,052 - $10,296	-300 Reduced 2.9%	10,053 $329,000
Q4 2017 Feb 05, 2018	SELL	$24.79 - $29.8 $49,332 - $59,302	-1,990 Reduced 16.12%	10,353 $257,000
Q3 2017 Nov 03, 2017	BUY	$26.26 - $29.17 $324,127 - $360,045	12,343	12,343 $360,000

Others Institutions Holding BSX

# of Institutions

1,323

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $109B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Account

Grimes & Company, Inc. Boston Scientific Corp Transaction History